LU63060A1 - - Google Patents

Info

Publication number
LU63060A1
LU63060A1 LU63060DA LU63060A1 LU 63060 A1 LU63060 A1 LU 63060A1 LU 63060D A LU63060D A LU 63060DA LU 63060 A1 LU63060 A1 LU 63060A1
Authority
LU
Luxembourg
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU63060A1 publication Critical patent/LU63060A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
LU63060D 1971-04-26 1971-04-26 LU63060A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU63060 1971-04-26

Publications (1)

Publication Number Publication Date
LU63060A1 true LU63060A1 (fr) 1971-08-26

Family

ID=19726690

Family Applications (1)

Application Number Title Priority Date Filing Date
LU63060D LU63060A1 (fr) 1971-04-26 1971-04-26

Country Status (6)

Country Link
CH (1) CH540695A (fr)
DE (1) DE2220504A1 (fr)
FR (1) FR2134503B1 (fr)
GB (1) GB1358001A (fr)
LU (1) LU63060A1 (fr)
NL (1) NL7205573A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9103110D0 (sv) * 1991-10-24 1991-10-24 Kabi Pharmacia Ab New drug formulation
CA2355829A1 (fr) * 1999-01-07 2000-07-13 Louise Templeton Formes posologiques orale multiparticulaires
ATE536867T1 (de) 2006-03-16 2011-12-15 Tris Pharma Inc Modifizierte freisetzungsformulierungen mit arznei-ion-austausch-harzkomplexen
CA2880456A1 (fr) 2012-08-15 2014-02-20 Tris Pharma, Inc. Comprime a croquer de methylphenidate a liberation modifiee
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US12458592B1 (en) 2017-09-24 2025-11-04 Tris Pharma, Inc. Extended release amphetamine tablets

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7017E (fr) *
BE560809A (fr) *

Also Published As

Publication number Publication date
GB1358001A (en) 1974-06-26
DE2220504A1 (de) 1973-02-15
FR2134503B1 (fr) 1976-07-02
CH540695A (fr) 1973-08-31
NL7205573A (fr) 1972-10-30
FR2134503A1 (fr) 1972-12-08

Similar Documents

Publication Publication Date Title
DK133986C (fr)
CS177846B2 (fr)
CS163843B1 (fr)
DK141284C (fr)
FR2121832A1 (fr)
FR2075377A5 (fr)
DE2152099B2 (fr)
DE2130017C3 (fr)
DE2117336C3 (fr)
DE2212858B2 (fr)
FI45116B (fr)
FI47520B (fr)
DE2110437C3 (fr)
FR2095019A5 (fr)
CS151770B1 (fr)
CS155466B1 (fr)
CS170186B2 (fr)
DE2105988A1 (fr)
CS153368B1 (fr)
DE2218589B2 (fr)
CS162891B1 (fr)
BG16941A1 (fr)
CH556428A (fr)
CH577971A5 (fr)
CH545888A (fr)